UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054789
Receipt number R000062613
Scientific Title Prospective observational study of factors affecting adenoma detection rate in colonoscopy
Date of disclosure of the study information 2024/06/26
Last modified on 2024/06/26 20:01:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prospective observational study of factors affecting adenoma detection rate in colonoscopy

Acronym

Prospective observational study of factors affecting adenoma detection rate in colonoscopy

Scientific Title

Prospective observational study of factors affecting adenoma detection rate in colonoscopy

Scientific Title:Acronym

Prospective observational study of factors affecting adenoma detection rate in colonoscopy

Region

Japan


Condition

Condition

Hyperplastic polyp, Sessile serrated lesion, Colorectal neoplasm

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To identify factors affecting adenoma detecting rate (ADR) in colonoscopy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Risk factors contributing to ADR

Key secondary outcomes

Patient background (age, gender, medical history, comorbidities, medication history, family history, etc.), examination time, presence of lesions, lesion characteristics (location, gross type, size), final pathology diagnosis, polyp detection rate, scope, whether CAD EYE (AI-based diagnostic aid) used


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients scheduled to undergo screening colonoscopy

Key exclusion criteria

1. patients under 20 years of age at the time consent is obtained
2. Cases deemed unsuitable for enrolment by the investigator or sub-investigator

Target sample size

3500


Research contact person

Name of lead principal investigator

1st name Motohiko
Middle name
Last name Kato

Organization

Keio University School of Medicine

Division name

Center for Diagnostic and Therapeutic Endoscopy

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-3353-1211

Email

motohikokato@keio.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Minezaki

Organization

Keio University School of Medicine

Division name

Division of Research and Development for Minimally Invasive Treatment, Cancer Center

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

TEL

03-3353-1211

Homepage URL


Email

d-mine@keio.jp


Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

FUJIFILM Holdings Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

eio University School of Medicine Ethics Committee

Address

35 Shinanomachi, Shinjuku-ku, Tokyo

Tel

03-3353-1211

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 06 Month 26 Day

Date of IRB

2023 Year 06 Month 26 Day

Anticipated trial start date

2023 Year 06 Month 26 Day

Last follow-up date

2024 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The following information is to be carried out and collected for observations and tests.
1) Patient background
Age, gender, preferences (extent of smoking and drinking habits), medical history, comorbidities, medication history, family history, blood test findings, imaging findings (X-ray, CT, MRI, ultrasound, digestive tract examination)
2) Lower gastrointestinal endoscopy
Examination time, presence or absence of lesions, characteristics of lesions (location, gross type, size), type of endoscope used, use of CAD EYE or not
3) Pathological findings
Final pathological diagnosis


Management information

Registered date

2024 Year 06 Month 26 Day

Last modified on

2024 Year 06 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062613